A metabolite of Thromboxane that is an in vivo markers of oxidative stress and platelet activation. It is associated with adverse cardiovascular events in Alzheimer''s Disease Anti-inflammatory Prevention Trial (ADAPT).
A metabolite of Thromboxane that is an in vivo markers of oxidative stress and platelet activation. It is associated with adverse cardiovascular events in Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT).
ChEBI: A thromboxane obtained by formal oxidation of the hemiacetal hydroxy function of thromboxane B2.